Stocks · Health care · Biological Products, (No Diagnostic Substances)

Invivyd, Inc.

IVVD Clue Score60
United States Fiscal year ends December CIK 0001832038 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Terrance McGuire
31 Dec 2024
Director
Sell indirect
103,474
$0.45
$46.10K
Terrance McGuire
30 Dec 2024
Director
Sell indirect
86,545
$0.48
$41.78K
Terrance McGuire
27 Dec 2024
Director
Sell indirect
83,744
$0.52
$43.65K
Terrance McGuire
26 Dec 2024
Director
Sell indirect
83,817
$0.54
$45.56K
Terrance McGuire
24 Dec 2024
Director
Sell indirect
68,161
$0.51
$34.50K
Terrance McGuire
23 Dec 2024
Director
Sell indirect
75,776
$0.45
$34.08K
Terrance McGuire
20 Dec 2024
Director
Sell indirect
119,805
$0.42
$50.73K
Terrance McGuire
19 Dec 2024
Director
Sell indirect
152,067
$0.43
$65.95K
Terrance McGuire
18 Dec 2024
Director
Sell indirect
74,764
$0.47
$35.09K
Terrance McGuire
17 Dec 2024
Director
Sell indirect
97,410
$0.48
$46.76K
Terrance McGuire
16 Dec 2024
Director
Sell indirect
65,359
$0.47
$30.51K
Terrance McGuire
12 Dec 2024
Director
Sell indirect
125,000
$0.58
$72.88K
Terrance McGuire
11 Dec 2024
Director
Sell indirect
160,400
$0.59
$94.81K
Terrance McGuire
10 Dec 2024
Director
Sell indirect
175,000
$0.59
$103.01K
Terrance McGuire
9 Dec 2024
Director
Sell indirect
150,000
$0.61
$91.56K
Terrance McGuire
29 May 2024
Director
Sell indirect
112,381
$1.66
$186.57K
Adimab, LLC
19 Jan 2024
10% owner
Sell
5,000,000
$3.95
$19.75M

What was left out

Form 4 filings counted 122
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 0
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 83,021,309
History held since 9 Aug 2021